المؤلفون: Shantzer LB; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Dougherty SC; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Bolte F; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Melson JW; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Reed DR; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Lynch AC; Department of Pharmacy, University of Virginia Health System, Charlottesville, VA., Gentzler RD; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Novicoff W; Department of Public Health Sciences and Orthopaedic Surgery, HSC, University of Virginia Health System, Charlottesville, VA., Hall RD; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA. Electronic address: rdh3q@uvahealth.org.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2023 Mar; Vol. 24 (2), pp. e60-e64. Date of Electronic Publication: 2022 Nov 26.

نوع المنشور: Case Reports; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/therapy, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Immunotherapy/adverse effects